Study setting {9}
MUI
SECONDARY
In this single-center prospective, triple-blinded, two-group, randomized trial, 60 patients will be recruited and randomly assigned to one of the two groups to test the effect of a PECS II block with ropivacaine 0.5% on the postoperative opioid demand (see Consolidated Standards of Reporting Trials flow diagram (CONSORT) [Trial flow diagramThe primary outcome parameter is the overall opioid demand given as intravenous MME during the first 24 h after extubation.The secondary outcome variables are the interval until extubation, ICU discharge, data on ICU, length of hospital stay (LOS), the VAS at 2, 4, 6, 12, and 24 h after extubation, and the Overall Benefit of Analgesia Score (OBAS) at 24 h after extubation [This study will be performed in the Innsbruck Medical University Hospital. All participants will be recruited by a medical specialist team (recruiting team) at the Medical University of Innsbruck (MUI) (Investigation Site). All data will be collected by the research team consisting of physicians and healthcare researchers. The study investigators will perform data analysis.